Purity CAS 114-07-8 Erythromycin Powder Erythromycin

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Erythromycin
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Erythromycin
• Name: Erythromycin Powder
• Assay: HPLC 99%
• Appearance: White Powder
• Color: White
• CAS No.: 114-07-8
• Mf: C37h67no13
• MW: 733.93
• Melting Point: 133 C
• Boiling Point: 719.69°c
• Density: 1.1436
• Test Method: HPLC
• Grade: Veterinary Grade
• Application: Antibiotic
• Specific: COA
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 5000kg/Month

Product Description

Purity CAS 114-07-8 Erythromycin Powder Erythromycin 

Product Description

Product Details

Product Name	Erythromycin
Appearance	White Powder
CAS No.	114-07-8
MF	C37H67NO13
MW	733.93

Erythromycin (EM, Er) is an alkaline antibiotic produced by streptomycin. Including erythromycin A (ErA), erythromycin B (ErB), erythromycin C (ErC), erythromycin D (ErD), erythromycin E (ErE), and erythromycin F (ErF). Its free base is for oral administration, and its lactinate can be injected. It belongs to the narrow spectrum of macrolide antibiotics and is commonly used as a substitute for penicillin resistant Gram positive bacterial infections and penicillin allergies. Its antibacterial spectrum is similar to penicillin.
In clinical application, it is commonly used for patients with Gram resistant bacterial infections resistant to penicillin and those allergic to penicillin. It can be used as the first choice for infant pneumonia and colitis caused by Legionella pneumonia, Mycoplasma pneumonia, Chlamydia trachomatis, and skin and soft tissue infections. It can also be used for respiratory tract infections caused by Streptococcus pyogenes and Streptococcus pneumoniae. The combination of this product and diphtheria antitoxin enhances the efficacy for white throat carriers.

Application&Function

Erythromycin is a motilin receptor agonist, and the spatial structure of the 14 membered lactone ring on the glycosidic chain of erythromycin molecule is similar to that of motilin. It can act as a motilin receptor agonist, producing a simulated motilin effect and inducing premature phase III contraction of MMC in fasting state, causing smooth muscle contraction in the stomach and duodenum. The gastric motility promoting effect of erythromycin is dose dependent. Low doses of erythromycin induce gastric contractions similar to spontaneous MMC, while high doses of erythromycin cause strong irregular gastric and duodenal contractions leading to vomiting, which is also the reason why erythromycin causes gastrointestinal reactions. Therefore, the dosage of erythromycin for promoting gastric motility should not be too high. The commonly used macrolide antibiotics have an antibacterial spectrum similar to penicillin, mainly used for patients allergic to penicillin or for infections caused by penicillin resistant Staphylococcus aureus. They can also be used for infections caused by streptococcus, pneumococcus, and diphtheria carriers.
purpose
Erythromycin can treat digestive system diseases, and EM has varying degrees of prokinetic effects on the entire gastrointestinal tract. There are mainly the following effects: promoting esophageal contraction and increasing lower esophageal sphincter pressure (LESP); Promote gastric antrum contraction and improve the coordination of gastric antrum and duodenal function; Inducing gastrointestinal migration complex movement; Promote colon movement and gallbladder contraction. Therefore, it can effectively treat gastrointestinal diseases.

Specification